Pathways to adaptive functioning in autism from early childhood to adolescence.


Journal

Autism research : official journal of the International Society for Autism Research
ISSN: 1939-3806
Titre abrégé: Autism Res
Pays: United States
ID NLM: 101461858

Informations de publication

Date de publication:
10 2022
Historique:
received: 22 04 2022
accepted: 15 07 2022
pubmed: 29 7 2022
medline: 13 10 2022
entrez: 28 7 2022
Statut: ppublish

Résumé

Adaptive functioning is lower in many autistic individuals to a greater extent than would be expected based on IQ. However, the clinical features associated with these difficulties are less well understood. This study examines longitudinal and contemporaneous associations of adaptive functioning in autistic youth across a wide ability range. Parent-reported autism symptoms, co-occurring emotional, behavioral and attention deficit hyperactivity disorder (ADHD) symptoms, and IQ were assessed in early childhood (M age 7 years; T1) and 6 years later in adolescence (M age 13 years; T2) in 179 autistic youth. Adaptive functioning was assessed at T2. Structural equation modeling estimated pathways to adaptive functioning from autism, and psychiatric symptoms at T1 and T2, testing whether associations were driven by continuity of behaviors from T1 to T2 or their contemporaneous effect at T2, or both, controlling for T1 IQ. Lower adaptive functioning at T2 was associated with higher T1 and T2 ADHD symptoms (β = -0.14, and β = -0.21) but not behavioral nor emotional symptoms at either timepoint. Lower adaptive functioning at T2 was also associated with lower T1 IQ (β = 0.43) and higher social communication symptoms (β = -0.37) at T2 but not T1, but the relationship with ADHD symptoms remained. Paths were not moderated by sex or IQ. Increased symptoms of ADHD, both in early childhood and contemporaneously, were associated with reduced adaptive functioning in adolescence. Co-occurring ADHD may be a modifiable risk factor for adaptive function impairments and should be routinely assessed and when present evidence-based treatments initiated which may benefit adaptive functioning outcomes. LAY SUMMARY: Adaptive functioning is lower in many autistic individuals to a greater extent than would be expected based on IQ. However, the clinical features associated with these difficulties are less well understood. In a community sample higher attention deficit/hyperactivity disorder (ADHD) symptoms, but not emotional or behavioral symptoms, in both early childhood and contemporaneously were associated with lower adaptive functioning in autistic adolescents. Co-occurring ADHD may be a modifiable risk factor for adaptive function difficulties in autism.

Identifiants

pubmed: 35899846
doi: 10.1002/aur.2785
pmc: PMC9796413
mid: EMS158861
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1883-1893

Subventions

Organisme : Wellcome Trust
ID : 213608
Pays : United Kingdom
Organisme : Department of Health
ID : RP-PG-1211-20016
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 213608/Z/18/Z
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. Autism Research published by International Society for Autism Research and Wiley Periodicals LLC.

Références

J Child Psychol Psychiatry. 2000 Jul;41(5):645-55
pubmed: 10946756
JAMA. 2006 Oct 25;296(16):1981-9
pubmed: 17062861
J Am Acad Child Adolesc Psychiatry. 2019 May;58(5):525-533.e3
pubmed: 31029198
JAMA Netw Open. 2021 Mar 1;4(3):e213155
pubmed: 33779737
J Am Acad Child Adolesc Psychiatry. 2006 Sep;45(9):1094-1103
pubmed: 16926617
Autism Res. 2019 Apr;12(4):645-657
pubmed: 30741482
Pediatrics. 2012 Nov;130 Suppl 2:S91-7
pubmed: 23118259
J Autism Dev Disord. 2015 Aug;45(8):2283-94
pubmed: 25737019
Autism. 2020 Jan;24(1):221-232
pubmed: 31215791
Am J Psychiatry. 2013 Mar;170(3):275-89
pubmed: 23360949
Dev Med Child Neurol. 2016 Feb;58(2):202-8
pubmed: 26077499
Dev Psychol. 2014 Mar;50(3):699-708
pubmed: 24001150
Eur Child Adolesc Psychiatry. 2017 Jan;26(1):123-136
pubmed: 27295115
Autism. 2016 May;20(4):442-62
pubmed: 26134030
J Autism Dev Disord. 1995 Apr;25(2):81-104
pubmed: 7559289
Autism. 2018 Nov;22(8):983-994
pubmed: 28914086
Autism Res. 2018 Feb;11(2):270-283
pubmed: 28941213
Psychol Bull. 1990 Mar;107(2):238-46
pubmed: 2320703
Autism. 2019 Oct;23(7):1630-1644
pubmed: 30818965
Psychol Med. 2011 Mar;41(3):619-27
pubmed: 21272389
Autism. 2015 Oct;19(7):774-84
pubmed: 25922445
J Autism Dev Disord. 2016 Feb;46(2):467-77
pubmed: 26349921
Autism Res. 2009 Apr;2(2):109-18
pubmed: 19455645
J Autism Dev Disord. 2017 Oct;47(10):3007-3017
pubmed: 28710532
Clin Child Fam Psychol Rev. 2021 Dec;24(4):744-764
pubmed: 34196895
Autism Res. 2016 Dec;9(12):1353-1363
pubmed: 27120552
Children (Basel). 2021 Jul 29;8(8):
pubmed: 34438549
J Am Acad Child Adolesc Psychiatry. 2001 Nov;40(11):1337-45
pubmed: 11699809
Autism. 2015 Jan;19(1):64-72
pubmed: 24275020
J Am Acad Child Adolesc Psychiatry. 2021 Aug;60(8):978-985
pubmed: 33220430
Br J Psychiatry. 2021 Jun;218(6):323-325
pubmed: 33198827
J Autism Dev Disord. 2006 Oct;36(7):863-70
pubmed: 16897401
J Autism Dev Disord. 2020 Jan;50(1):42-50
pubmed: 31520244
J Clin Child Adolesc Psychol. 2019 Nov-Dec;48(6):840-854
pubmed: 29601216
J Child Psychol Psychiatry. 2021 Jun;62(6):680-700
pubmed: 32845025
J Intellect Disabil Res. 2005 Sep;49(Pt 9):672-81
pubmed: 16108984
Psychol Bull. 2020 Jan;146(1):1-29
pubmed: 31763860
JAMA Psychiatry. 2015 Mar;72(3):276-83
pubmed: 25629657
Eur Child Adolesc Psychiatry. 2021 Oct 22;:
pubmed: 34677682
Autism Res. 2009 Dec;2(6):322-33
pubmed: 19998356
Autism Res. 2022 Oct;15(10):1883-1893
pubmed: 35899846
JAMA Netw Open. 2021 Mar 1;4(3):e212530
pubmed: 33779740
J Autism Dev Disord. 2011 Aug;41(8):1007-18
pubmed: 21042872

Auteurs

Susie Chandler (S)

Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Virginia Carter Leno (V)

Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Philippa White (P)

Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Isabel Yorke (I)

Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Matthew J Hollocks (MJ)

Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
South London and Maudsley NHS Foundation Trust (SLaM), London, UK.

Gillian Baird (G)

Guy's and St Thomas' NHS Foundation Trust, London, UK.

Andrew Pickles (A)

Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Maudsley Biomedical Research Centre for Mental Health, London, UK.

Emily Simonoff (E)

Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
South London and Maudsley NHS Foundation Trust (SLaM), London, UK.
Maudsley Biomedical Research Centre for Mental Health, London, UK.

Tony Charman (T)

Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
South London and Maudsley NHS Foundation Trust (SLaM), London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH